Is a complete TPEX/6617 research report available?

No complete published report is available for tpex/6617 (TPEX/6617) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/6617 (TPEX/6617)

Taipei Exchange: TPEX/6617 · TWD

NT$137

+1.50 (+1.1%)· Recorded snapshot

Market cap	16.4B
Revenue (ttm)	42.2M
Net income (ttm)	-164.5M
EPS (ttm)	-NT$1.35
Shares out	121.2M
Volume	164,000
Beta	0.29

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 42.2M
Net income (ttm): -164.5M
EPS (ttm): -NT$1.35
Market cap: 16.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All TPEX/6617 indicators

Market & fundamental data

Available fields

172

Groups with data

Currency

TWD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	TW
Enterprise value	TWD 14.8B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Industry PE Fwd	32.87
Isin	KYG409471060
Last refreshed	2026-09-08
Market cap	TWD 16.4B
Price	TWD 137
Price currency	TWD
Sector	Healthcare
Sector PE	88.9
Sector PE Fwd	27.78
Sic	2836
Symbol	tpex/6617
Website	https://www.gongwinbiopharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.01%
FCF yield	-1.21%
P/B ratio	7.04x
P/S ratio	387.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	63.09%
Gross Profit	TWD 26.6M
Gross Profit Growth	144.86%
Gross Profit Growth Q	-7.26%
Gross Profit Growth5 Y	102.31%
Net Income	TWD -164.5M
Net Income Growth Years	0%
Pretax Margin	-417.11%
ROA	-5.65
Roa5y	-6.33
ROCE	-9.91
ROE	-7.36
Roe5y	-10.62
ROIC	-5.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	39.25%
Cagr3y	-10.56%
Cagr5y	-9.18%
EPS Growth Years	0
Revenue Growth	22.49x
Revenue Growth Q	45.05x
Revenue Growth Qo Q	33.99x
Revenue Growth Quarters	2x
Revenue Growth Years	3x
Revenue Growth3 Y	164.11x
Revenue Growth5 Y	119.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.02
Assets	TWD 2.6B
Cash	TWD 1.7B
Current Assets	TWD 1.7B
Current Liabilities	TWD 210.1M
Debt	TWD 149.9M
Debt Equity	TWD 0.06
Debt FCF	TWD -0.76
Equity	TWD 2.3B
Interest Coverage	-59.05
Liabilities	TWD 317.3M
Long Term Assets	TWD 922M
Long Term Liabilities	TWD 107.2M
Net Cash	TWD 1.5B
Net Cash By Market Cap	TWD 9.29
Net Cash Growth	1.86%
Net Debt Equity	TWD -0.65
Tangible Book Value	TWD 2.3B
Tangible Book Value Per Share	TWD 19.22
WACC	5.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.19
Inventory Turnover	3.84
Net Working Capital	TWD -18.1M
Quick ratio	8.05
Working Capital	TWD 1.5B
Working Capital Turnover	TWD 0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	39.22%
200-day SMA	80.91
3Y total return	-28.46%
50-day SMA	100.3
50-day SMA vs 200-day SMA	50over200
5Y total return	-38.19%
All Time High	457
All Time High Change	-68.93%
All Time High Date	2022-08-17
All Time Low	47.5
All Time Low Change	198.95%
All Time Low Date	2017-07-19
ATR	7.82
Beta	0.29
Beta1y	0.11
Beta2y	0.42
Ch YTD	64.93
High	143
High52	142
High52 Date	2026-09-08
High52ch	-3.87%
Low	135.5
Low52	58.3
Low52 Date	2026-04-23
Low52ch	134.13%
Ma50ch	41.55%
Price vs 200-day SMA	75.49%
RSI	69.7
RSI Monthly	57.37
RSI Weekly	70.99
Sharpe ratio	0.7x
Sharpe Ratio3y	-0.04x
Sharpe Ratio5y	-0.02x
Sortino ratio	1.35
Sortino Ratio3y	0.05
Sortino Ratio5y	0.09
Total Return	3.39%
Tr YTD	64.93
Tr1m	62.1%
Tr1w	17.84%
Tr3m	108.21%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	53,680,094%
Net Borrowing	26,784,000
Shares Insiders	24.58%
Shares Institutions	0.04%
Shares Out	121,210,000
Shares Qo Q	-1.07%
Shares Yo Y	-3.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,078,171.3x
Bv Per Share	19.23
CAPEX	TWD -2.4M
Ch1m	62.1
Ch1w	17.84
Ch1y	39.22
Ch3m	108.2
Ch3y	-28.46
Ch5y	-38.92
Ch6m	77.5
Change	1.11%
Change From Open	-3.87
Close	135
Days Gap	5.19
Depreciation Amortization	8,602,000
Dollar Volume	22,386,000
Earnings Date	2026-11-13
EBIT	TWD -241.2M
EBITDA	TWD -232.6M
EPS	TWD -1.35
F Score	2
FCF	TWD -198.3M
FCF EV Yield	-1.34x
FCF Per Share	TWD -1.64
Financing CF	-90,528,000
Fiscal Year End	December
Founded	2,014
Income Tax	TWD 49,000
Investing CF	365,993,000
Is Primary Listing	1
Last Earnings Date	2025-11-21
Last Report Date	2026-06-30
Ma150	80.29
Ma150ch	76.86%
Ma20	112.4
Ma20ch	26.32%
Net CF	177,979,000
Next Earnings Date	2026-11-13
Open	142
Position In Range	13.33
Ppne	318,720,000
Price Date	2026-09-08
Ptbv Ratio	7.04
Relative Volume	0.15x
Revenue	42,224,000x
Tax By Revenue	0.12x
Tr6m	77.5%
Volume	164,000
Z Score	18.8

TPEX/6617 (TPEX/6617)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6617

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6617 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6617

Frequently asked questions